Purpose: We investigated the characteristics and capability of interstitial MR lymphography in mice using gado‰uorine 8, gado‰uorine M, and gado‰uorine P.
Introduction
The lymphatic system is a complicated network of lymph vessels, organs, and lymph nodes that oŠers frontline defense against infections and carcinomas. Therefore, its assessment is important in the investigation of many pathological processes. Mice are the most popular experimental animals to model human disease because of the ease of their handling and their short life span and fast reproductive turnover. However, knowledge of the lymphatic pathway in mice is limited. Establishing a method to assess the mouse lymphatic system could aid research in oncology and immunology using mice as experimental platforms.
Recently, several methods have been introduced to assess the lymphatic system, including sonography, computed tomography (CT), and magnetic resonance (MR) imaging. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Contrast-enhanced sonography can survey only to a limited depth from the detector, and so, it is not suitable for detecting the deep lymphatic system. CT lymphography using water-soluble, nanoparticulate, iodine contrast, oil-in-water emulsion has been reported as a feasible method to detect lymph nodes with high resolution images. However, the inherently low tissue contrast with this method makes CT detection of the exact location of the deep lymphatic system di‹cult, especially in rodents. MR imaging seems promising for investigating the lymphatic system because it provides high resolution and high tissue contrast.
MR lymphography after interstitial administration of a contrast agent visualizes the lymphatic pathway and allows noninvasive and 3-dimensional (3D) analysis of that pathway in living mice. [6] [7] [8] [9] [10] The contrast agent is injected, enters the lymphatic capillaries, and is transported with the lymphatic ‰ow to the lymph nodes, allowing functional evaluation of the lymphatic pathway as well as morphological evaluation. This method is used to detect sentinel lymph nodes.
Interstitial MR lymphography can be performed with several types of contrast agents, such as extracellular gadolinium agents, extracellular contrast agents encapsulated in liposomes, superparamagnetic iron oxide particles, polymeric compounds, and lipophilic compounds that form micelles. 11 Among these, extracellular gadolinium chelates show nonspeciˆc distribution and fast elimination. Gado‰uorine 8 (Bayer Schering Pharma AG, Berlin, Germany) is a macrocyclic gadolinium chelate with per‰uorinated side chain that permits the formation of micelles of this compound in aqueous solution and this compound's e‹cient retention in the lymph nodes. Gado‰uorine 8 has been used for interstitial MR lymphography in dogs, 12 pigs, 12,13 rabbits, 12,14 and mice. 8, 15 Gado‰uorine M (Bayer Schering Pharma AG), another micelle-forming contrast agent, has been used to detect central nervous system lesions, 16, 17 assess peripheral nerve injuries, 18 evaluate atherosclerotic plaques, 19 and track cells. 20 Visualization of lymph nodes in rabbits has been reported using intravenous injection of gado‰uorine M. 21, 22 Gado‰uo-rine P (invivoContrast GmbH, Berlin, Germany) 23 is a novel micelle-forming contrast agent developed for preclinical application; it is commercially available but not approved for clinical use. The application of gado‰uorine M or gado‰uorine P to interstitial MR lymphography has not been reported.
In this study, we performed interstitial MR lymphography after injecting gado‰uorine 8, gado‰uo-rine M, or gado‰uorine P subcutaneously into the right rear footpads of healthy mice. Moreover, we assessed the lymphatic pathway from the right and left rear feet or the tail using gado‰uorine M. We aimed to investigate the characteristics and capability of interstitial MR lymphography using gado‰uorines in mice.
Materials and Methods

Animals
We obtained female BALB/c mice from Japan SLC (Hamamatsu, Japan) and maintained them in a speciˆc pathologen-free facility. They weighed 24.1±0.7 grams (mean±SD) and received food and water ad libitum except for dietary preparation before MR imaging. Animals were handled according to the guidelines of the host institution, and experiments were approved by the institution's animal research committee.
Contrast agents
We used gado‰uorine 8, gado‰uorine M, and gado‰uorine P for interstitial MR lymphography (Fig. 1) . Original solution concentrations were 50 mmol Gd/mL (gado‰uorine 8), 250 mmol Gd/mL (gado‰uorine M), and 25 mmol Gd/mL (gado‰uo-rine P). Gado‰uorine 8 and gado‰uorine M were diluted with phosphate-buŠered saline to 25 mmol Gd/mL. The injection dose wasˆxed at 0.5 mmol Gd and the volume per mouse at 20 mL in each MR lymphography study.
Imaging procedures
We performed imaging using a compact MR imaging system (MRmini; MRTechnology, Tsukuba, Japan), consisting of a one-tesla permanent magnet and a solenoid coil of 30-mm inner diameter. 24, 25 The maximum amplitude and slew rate of the gradient system were 140 mT/m and 350 T/m/s, respectively. The mice were fed only autoclaved potatoes for 24 hours before imaging to reduce high signal intensity in the gastrointestinal system and achieve fewer artifacts and better image quality. 8 The mice were anesthetized with 4z iso‰urane in air, and anesthesia was maintained during imaging with 1.5z iso‰urane. They wereˆxed in prone position on a 28-mm-wide plate holder, with mouse and holder gently wrapped together with tape to reduce motion artifacts; tight wrapping was avoided so that lymph ‰ow was not disturbed. MR imaging from the upper pole of the kidney to the popliteal space (abdominopelvic imaging) or from the neck to the lower pole of the kidney (thoracoabdominal imaging) was performed.
We obtained scout images in the coronal plane using T 1 -weighted 3D fast low-angle shot (FLASH) sequence with parameters: repetition time (TR), 30 ms; echo time (TE), 2.1 ms; ‰ip angle (FA), 369 ; inplane matrix, 256×64; 8 slab partitions; one signal 
Sequential MR lymphography
We performed interstitial MR lymphography after subcutaneous injection of gado‰uorine 8, gado‰uorine M, or gado‰uorine P into the right rear footpads of healthy mice and compared visualization of lymph nodes among the 3 contrast agents. Mice wereˆxed on the plate holder under anesthesia. To prevent hypothermia from anesthesia, we warmed the plate holder with circulating heated water. Prior to contrast injection, we performed abdominopelvic and thoracoabdominal imaging with TR of 30 ms and FA of 459 . After completion of baseline imaging, we injected mice with gado‰uorine 8, gado‰uorine M, or gado‰uorine P subcutaneously in the dorsal side of the right rear footpad using a microsyringe and applied gentle massage for 30 s. Care was taken to avoid contact between the needle and vein. Only the tape attached to the posterior limbs was removed before injection; the mouse trunk was keptˆxed to the plate holder during injection. Abdominopelvic images were collected 5, 10, 15, 30, 45, and 60 min after injection, and thoracoabdominal images were collected 22 and 67 min after injection. Each of the 3 contrast agents was investigated in each of the 6 mice, with a one-week interval between administration of each contrast agent. Three pairs of mice received the agents in various order: 2 mice were injected with gado‰uorine 8 followed by gado‰uorine P and gado‰uorine M; two were injected with gado‰uo-rine P followed by gado‰uorine M and gado‰uo-rine 8; and two were injected with gado‰uorine M followed by gado‰uorine 8 and gado‰uorine P.
We quantitatively evaluated the time course of contrast enhancement for the right popliteal, sacral, and iliac lymph nodes on abdominopelvic images. We set elliptical regions of interest (ROIs) for the lymph nodes and measured signal intensities. We quantitatively evaluated contrast enhancement for the liver and kidney on the thoracoabdominal images. We selected 3 ROIs in the liver to avoid inclusion of major vascular structures and determined the mean value of signal intensities in the 3 ROIs. We set an ROI for the parenchyma of each kidney to avoid inclusion of the collecting system and deˆned the mean value of signal intensities in both ROIs as the signal intensity of the kidney. We deˆned contrast ratio as the ratio of signal intensity on postcontrast images to that on precontrast images. We statistically tested the diŠerences in contrast ratios in the lymph nodes, liver, and kidney among the 3 contrast agents for each time point after contrast injection. We measured signal intensity on the source images using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
To evaluate biliary excretion, we visually assessed the in‰ux of the contrast agent into the duodenum, determining the imageˆrst showing deˆ-nite contrast enhancement in the duodenum and deˆning the time of appearance in the duodenum. Similarly, we visually evaluated signal intensity of the bladder to assess urinary excretion and deˆned the time of appearance in the bladder.
Lymphatic pathways from various sites
We performed interstitial MR lymphography after subcutaneous injection of gado‰uorine M into various sites of healthy mice and assessed visualization of the lymphatic pathway. We did not obtain baseline images. Under anesthesia, 3 mice were injected subcutaneously into the right rear footpad with gado‰uorine M using a microsyringe, massaged gently for 30 s, andˆxed on the plate holder. We performed abdominopelvic imaging followed by thoracoabdominal imaging with TR of 40 ms and FA of 649 . One week later, these 3 mice were injected with gado‰uorine M into the left rear footpad and similarly underwent MR lymphography to assess right-to-left diŠerence in the lymphatic pathway. We visually assessed contrast enhancement in the lymph nodes.
We similarly studied lymph drainage from the tail in the other 3 mice-performed MR lymphography after subcutaneous injection of gado‰uorine M into the right side of the proximal tail at a site one cm distal to the tail base and one week later, examined the same 3 mice after injection of gado‰uo-rine M into the left side of the proximal tail.
Statistical analysis
We analyzed statistics using Kruskal-Wallis test followed by Bonferroni's method. Pº.05 was considered statistically signiˆcant. All statistical computations were performed using StatView software version 5.0 (SAS Institute, Cary, NC, USA).
Results
Sequential MR lymphography
Six mice underwent interstitial MR lymphography after subcutaneous injection of gado‰uorine 8, gado‰uorine M, or gado‰uorine P in the right rear footpad, which demonstrated contrast enhancement of the right popliteal, sacral, and iliac lymph nodes in all mice at 5 minutes (Fig. 2) . Visual comparison indicated no deˆnite diŠerence in lymph node enhancement at 5 minutes among the 3 agents. Although lymph node signal decreased gradually, substantial enhancement was recognized until 30 min in 4 mice and 45 min in 2 mice after gado‰uorine 8 injection, until 30 min in 5 mice and 45 min in one mouse after gado‰uorine M injection, and until 15 min in 5 mice and 45 min in one mouse after gado‰uorine P injection. One mouse showed contrast enhancement in the right inguinal and proper axillary lymph nodes after injection of each agent. We observed multiple areas of enhancement between the upper poles of both kidneys in all mice. One week after injection, we observed no retention of contrast agent in the lymph nodes and neither local nor systemic adverse reaction.
On quantitative analysis, the contrast ratio for each lymph node peaked 5 min after contrast injection and decreased gradually (Fig. 3) . The contrast ratio in the popliteal node did not diŠer among the 3 agents. The contrast ratio in the sacral node was signiˆcantly greater for gado‰uorine 8 and gado‰uorine M than for gado‰uorine P at all time points after contrast injection. The contrast ratio in the iliac node was signiˆcantly larger at 10 min or later for gado‰uorine 8 and from 10 to 30 min for gado‰uorine M than that for gado‰uorine P. We found no signiˆcant diŠerences in contrast ratios between gado‰uorine 8 and gado‰uorine M.
Liver signal increased gradually after subcutaneous injection of gado‰uorine 8 or gado‰uorine P and remained unchanged after gado‰uorine M injection. On quantitative analysis, the contrast ratio in the liver at 22 min was signiˆcantly larger for gado‰uorine 8 or gado‰uorine P than for gado‰uo-rine M (Pº0.0001, Pº0.0001) and signiˆcantly larger for gado‰uorine P than for gado‰uorine 8 (P＝0.0285) ( Table 1 ). The contrast ratio in the liver at 67 min was signiˆcantly larger for gado‰uo-rine 8 or gado‰uorine P than for gado‰uorine M (Pº0.0001, Pº0.0001), and there was no signiˆ-cant diŠerence between gado‰uorine 8 and gado‰uorine P (P＝0.9947). We observed excretion into Values are presented as mean±standard error (SE). the duodenum in all mice after gado‰uorine P injection; the time of appearance in the duodenum was 15 min in one mouse and 30 min in 5 mice. Excretion into the duodenum was not found for gado‰uorine 8 or gado‰uorine M. Although contrast enhancement in the kidney was not clearly shown for any of the 3 agents (Table 2) , excretion into the bladder was demonstrated in all mice after injection of gado‰uorine M or gado‰uorine P. The time of appearance in the bladder was 5 min in 5 mice and 10 min in one mouse for gado‰uorine M and 5 min in 3 mice and 10 min in 3 mice for gado‰uorine P. Excretion into the bladder was not found for gado‰uorine 8.
Lymphatic pathways from various sites
We assessed the lymphatic pathways from the right and left rear footpads of 3 mice by interstitial MR lymphography using gado‰uorine M. Contrast enhancement was demonstrated in the ipsilateral popliteal, sacral, and iliac lymph nodes in all 6 studies performed in the 3 mice; the contralateral lymph nodes were not enhanced (Fig. 4, Table 3 ). The right inguinal and proper axillary lymph nodes were also enhanced in one mouse after injection into the right rear footpad. The left lumbar aortic lymph node was enhanced in 2 mice after injection into the left rear footpad.
We assessed the lymphatic pathway from the right and left sides of the tail in the other 3 mice. Contrast enhancement in the ipsilateral sacral and iliac lymph nodes was demonstrated in all 6 studies performed in the 3 mice (Fig. 5, Table 3 ). The left sacral and left iliac nodes were also enhanced in 2 mice after injection into the right side of the tail. The popliteal lymph nodes were not enhanced. The left inguinal and left proper axillary nodes were enhanced in 2 mice after injection into either the right or left side of the tail; one of these also showed contrast enhancement in the right inguinal lymph node after injection into the right side of the tail. Among the 6 MR lymphography studies, bilateral lumbar aortic lymph nodes were enhanced in one study, and lumbar aortic lymph nodes ipsilateral to the injection site were enhanced in 4 other studies.
We observed additional areas of enhancement between the upper poles of both kidneys in all studies using footpad or tail injection. The interval between contrast injection and start of data collection was 8.0±0.2 min for abdominopelvic imaging and 16.5±0.8 min for thoracoabdominal imaging. 
Axillary, proper axillary lymph node; Lumbar, lumbar aortic lymph node; R, right; L, left. ＋, present; -, absent.
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Discussion
We performed interstitial MR lymphography in healthy mice and compared visualization of lymph nodes among gado‰uorine 8, gado‰uorine M, and gado‰uorine P. Clear contrast enhancement was demonstrated in the lymph nodes after subcutaneous injection of each contrast agent into the right rear footpad. Gado‰uorine 8 has been applied to interstitial MR lymphography in animal experiments, 8, 12, 15 and its ability to delineate small lymph nodes in healthy mice has been reported. 15 In this study, we demonstrated that interstitial MR lymphography using gado‰uorine M or gado‰uorine P also allows assessment of the lymphatic pathway in healthy mice.
Contrast enhancement in the lymph nodes peaked 5 min after subcutaneous injection of each agent and gradually declined; however, lymph node enhancement was apparent for a while. Quantitative analysis demonstrated comparable contrast eŠects of gado‰uorine 8 and gado‰uorine M and a mildly weaker eŠect of gado‰uorine P. On visual assessment, enhancement in the lymph nodes was still detectable 30 min after injection of gado‰uo-rine 8 or gado‰uorine M but became obscure sooner after gado‰uorine P injection. A prolonged imaging time window allows acquisitions of high resolution images and images in multipleˆelds of view and contributes to the ‰exibility of the experimental protocol. Although all 3 gado‰uorines are acceptable for interstitial MR lymphography, gado‰uorine 8 or gado‰uorine M may be better. Extracellular gadolinium chelates have the advantage of wide availability and have been investigated as contrast agents for interstitial MR lymphography. Extracellular gadolinium chelates' small molecular size permits only a small amount to reach the lymphatic system. These agents have also demonstrated rapid wash out and rather low relaxivity. 11 Gadoxetate disodium, a hepatobiliary contrast agent, has high T 1 relaxivity and seems useful in MR lymphography but showed similar magnitude and temporal pattern to lymph node enhancement in a recent comparison study with the extracellular gadolinium chelate. 10 Compared to these contrast agents, the gado‰uorines have an advantage in prolonging the imaging time window.
Contrast enhancement in the liver was demonstrated after subcutaneous injection of gado‰uo-rine 8 or gado‰uorine P but not seen after injection of gado‰uorine M. Enhancement within the duodenum, indicating biliary excretion, was observed for gado‰uorine P but not for gado‰uorine 8. Gado‰uorine P may be taken up by hepatocytes, whereas gado‰uorine 8 may accumulate in the KupŠer cells. We observed enhancement in the bladder, indicating urinary excretion, after subcutaneous injection of gado‰uorine M or gado‰uorine P but not after injection of gado‰uorine 8. Our results indicate clear diŠerences in the kinetics of the 3 micelleforming contrast agents after subcutaneous injection. When gado‰uorine P was developed as a successor of gado‰uorine M, it was designed for clinical use, and a shorter half-life was an important issue. 26 Hence, the evident biliary or urinary excre-tion of gado‰uorine P in the present study seems reasonable.
Gado‰uorine M injected into both right and left rear footpads or both sides of the tail delineated the lymphatic pathway from the respective injection site. To increase the throughput of experiments, we acquired images only after injection of the contrast agent without precontrast imaging. Restraint and positioning of mice and adjustment of the MR scanner after contrast injection delayed commencement of data acquisition. However, retention of gado‰uorine M in the lymph nodes permitted clear nodal enhancement. The noninvasive nature of MR lymphography allowed comparison of the lymphatic pathway from 2 diŠerent sites in a given mousethe right and left footpads or the right and left sides of the tail.
Contrast enhancement has been demonstrated in the right popliteal, sacral, and iliac lymph nodes after subcutaneous injection of gado‰uorine 8 into the right footpad in healthy mice. 15 In the present study, we demonstrated that lymph ‰ow reached the ipsilateral popliteal, sacral, and iliac nodes after subcutaneous injection into the rear footpad regardless of right-or left-side injection, indicating the presence of laterality in the lymphatic pathway of mice. Lymph ‰ow from the tail did not enter the popliteal node but reached the ipsilateral sacral and iliac nodes. In 2 of the 3 mice, we observed additional enhancement in the left sacral and iliac nodes after injection into the right side of the tail. This may represent incomplete laterality of lymph ‰ow from the tail or dispersion of contrast agent injected into the right side of the tail to the left side of the tail due to the limited interstitial space in the tail. Decreased injection volume may facilitate determination of the lymphatic pathway from the injection site. Our observation of contrast enhancement in the inguinal and proper axillary lymph nodes implied the presence of an additional lymphatic pathway. Enhancement of the ipsilateral proper axillary node when the inguinal node was enhanced indicated a connection of the lymphatic pathway between the two. 27 We observed enhanced areas between the upper poles of the right and left kidney in all MR lymphography examinations. In a previous study based on ex vivo ‰uorescence imaging after injection of quantum dots, many structures enhanced with gado‰uorine 8 injection were indicated to represent lymph vessels rather than nodes, such as cisterna chyli. 15 In the present study, we did not analyze enhanced areas near the kidney. MR lymphography with another agent or in combination with ‰uores-cence imaging would aid assessment of the lymphatic pathway near the kidney.
Conclusions
We assessed the characteristics of gado‰uorine 8, gado‰uorine M, and gado‰uorine P for interstitial MR lymphography and observed contrast enhancement in the lymph nodes soon after subcutaneous injection of each agent, which remained long enough to provide a su‹cient imaging time window. These 3 contrast agents appeared to be eligible candidates for use as MR lymphographic agents. Compared to gado‰uorine P, the other 2 agents showed mildly stronger enhancement in the lymph nodes. We found diŠerences in accumulation in the liver, biliary excretion, and urinary excretion among the 3 contrast agents after subcutaneous injection. Interstitial MR lymphography using gado‰uorine M allowed repeated assessment of the lymphatic pathway in a given mouse. Interstitial MR lymphography using gado‰uorines is expected to aid research of the mouse lymphatic system.
